Skip to main content
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1985 Jun;19(3):163–167. doi: 10.1007/BF00199221

Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patients

Etsuro Yanagawa 1,, Atsushi Uchida 1, Michael Moore 1, Michael Micksche 4
PMCID: PMC11039094  PMID: 2408742

Abstract

Tumor-associated macrophages (TAM) isolated from pleural effusions and ascites fluids of cancer patients were tested for cytotoxicity against freshly isolated autologous tumor cells and K562 in a 4-h51 Cr-release assay, and in vitro effects of OK432 (a streptococcal preparation) and partially purified human leukocyte interferon (IFN) on their cytotoxicities were examined. Positive cytotoxicities against K562 were recorded for TAM samples from 2 of 23 pleural effusions and 3 of 10 ascites specimens. Tumor-associated macrophages were not cytotoxic to autologous tumor cells, while low but significant lysis was observed with tumor-associated lymphocytes (TAL) samples from 2 of 13 pleural effusions and 1 of 6 ascites specimens. In vitro treatment with OK432 resulted in an enhancement of natural cytotoxicity in 4 of 13 TAM and 10 of 15 TAL samples. An induction or augmentation of autologous tumor killing activity by OK432 was observed in 2 of 10 TAM and 8 of 11 TAL samples. In contrast, IFN failed to induce autologous tumor killing activity, although IFN-enhanced lysis of K562 was detected in 1 of 7 TAM and 2 of 9 TAL samples. These results indicated that autologous tumor killing and natural cytotoxic activities were defective in macrophages and lymphocytes at the site of the tumor growth, and both activities were strongly enhanced by OK432 rather than IFN.

Keywords: Interferon, Pleural Effusion, Ascites Fluid, Autologous Tumor, Autologous Tumor Cell

References

  • 1.Allavena P, Introna M, Sessa C, Mangioni C, Mantovani A. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells. J Natl Cancer Inst. 1982;68:555. [PubMed] [Google Scholar]
  • 2.Becker S, Kiessling R, Leen N, Klein G. Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma. J Natl Cancer Inst. 1978;61:1495. [PubMed] [Google Scholar]
  • 3.de Vries JE, Meyring M, van Dongren A, Rümke P. The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effect of lymphocytes from healthy donors. Int J Cancer. 1975;15:391. doi: 10.1002/ijc.2910150305. [DOI] [PubMed] [Google Scholar]
  • 4.Fisher DG, Golighly MG, Koren HS. Potentiation of the cytolytic activity of peripheral blood monocytes by lymphokines and interferon. J Immunol. 1982;130:1220. [PubMed] [Google Scholar]
  • 5.Freundlich B, Trinchieri G, Perussia B, Zurier RB. The cytotoxic effector cells in preparations of adherent mononuclear cells from human peripheral blood. J Immunol. 1984;132:1255. [PubMed] [Google Scholar]
  • 6.Haskill S, Koren H, Becker S, Fowler W, Walton L. Mononuclear-cell infiltration in ovarian cancer. III. Suppressor-cell and ADCC activity of macrophages from ascitic and solid ovarian tumours. Br J Cancer. 1982;45:747. doi: 10.1038/bjc.1982.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Klein E, Vánky F. Natural and activated cytotoxic lymphocytes which act on autologous and allogeneic tumor cells. Cancer Immunol Immunother. 1981;11:183. [Google Scholar]
  • 8.Lozzio CB, Lozzio BB. Human chronic myeloid leukemia cell-line with positive Philadelphia chromosome. Blood. 1975;45:321. [PubMed] [Google Scholar]
  • 9.Mantovani A, Allavena P, Sessa C, Bolis G, Mangioni C. Natural killer activity of lymphoid cells isolated from human ovarian tumors. Int J Cancer. 1980;25:573. doi: 10.1002/ijc.2910250505. [DOI] [PubMed] [Google Scholar]
  • 10.Mantovani A, Polentarutti N, Peri G, Shavit ZB, Vecchi A, Bolis G, Mangioni C. Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumors. J Natl Cancer Inst. 1980;64:1307. doi: 10.1093/jnci/64.6.1307. [DOI] [PubMed] [Google Scholar]
  • 11.Moore M, Potter MR. Enhancement of human natural cell-mediated cytotoxicity by interferon. Br J Cancer. 1980;41:378. doi: 10.1038/bjc.1980.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Moore M, Vose BM. Extravascular natural cytotoxicity in man: anti-K562 activity of lymph-node and tumour-infiltrating lymphocytes. Int J Cancer. 1981;27:265. doi: 10.1002/ijc.2910270303. [DOI] [PubMed] [Google Scholar]
  • 13.Peri G, Polentarutti N, Sessa C, Mangioni C, Mantovani A. Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin. Int J Cancer. 1981;28:143. doi: 10.1002/ijc.2910280206. [DOI] [PubMed] [Google Scholar]
  • 14.Uchida A. Lysis of fresh tumor cells by autologous blood and tumor-associated natural killer cells. In: Hoshino T, Koren HS, Uchida A, editors. Natural killer activity and its regulation. Amsterdam: Excerpta Medica; 1984. p. 341. [Google Scholar]
  • 15.Uchida A, Michsche M. Natural killer cells in carcinomatous pleural effusions. Cancer Immunol Immunother. 1981;11:131. [Google Scholar]
  • 16.Uchida A, Micksche M. Intrapleural administration of OK432 in cancer patients: activation of NK cells and reduction of suppressor cells. Int J Cancer. 1983;31:1. doi: 10.1002/ijc.2910310102. [DOI] [PubMed] [Google Scholar]
  • 17.Uchida A, Micksche M. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions. Int J Cancer. 1983;32:37. doi: 10.1002/ijc.2910320107. [DOI] [PubMed] [Google Scholar]
  • 18.Uchida A, Micksche M. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432. J Natl Cancer Inst. 1983;71:673. [PubMed] [Google Scholar]
  • 19.Uchida A, Yagita M, Hoshino T. Augmentation of natural and autotumor killing activity by OK432. In: Hoshino T, Koren HS, Uchida A, editors. Natural killer activity and its regulation. Amsterdam: Excerpta Medica; 1984. p. 220. [Google Scholar]
  • 20.Uchida A, Yanagawa E. Natural cytotoxicity of human blood monocytes: production of monocyte cytotoxic factors (MCF) during interaction with tumor cells. Immunol Lett. 1984;8:311. doi: 10.1016/0165-2478(84)90016-6. [DOI] [PubMed] [Google Scholar]
  • 21.Vánky F, Argov SA, Einhorn SA, Klein E. Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphocytes. J Exp Med. 1980;151:1151. doi: 10.1084/jem.151.5.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Vánky F, Masucci MG, Bejarano MT, Klein E. Lysis of tumor biopsy cells by blood lymphocyte subsets of various densities. Autologous and allogeneic studies. Int J Cancer. 1984;33:185. doi: 10.1002/ijc.2910330206. [DOI] [PubMed] [Google Scholar]
  • 23.Vose BM. Cytotoxicity of adherent cells associated with some human tumours and lung tissues. Cancer Immunol Immunother. 1978;5:173. [Google Scholar]
  • 24.Vose BM, Vánky F, Klein E. Human tumour-lymphocyte interaction in vitro. V. Comparison of the reactivity of tumour infiltrating, blood and lymph-node lymphocytes with autologous tumour cells. Int J Cancer. 1977;24:895. doi: 10.1002/ijc.2910200612. [DOI] [PubMed] [Google Scholar]
  • 25.Yanagawa E, Uchida A, Kokoschka EM, Micksche M. Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patients. Cancer Immunol Immunother. 1984;16:131. doi: 10.1007/BF00205418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Yanagawa E, Uchida A, Micksche M. Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432. Cancer Immunol Immunother. 1984;17:1. doi: 10.1007/BF00205490. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES